Ruonan Wang

机构：nLIGHT (United States), Liaoning Normal University, Guangdong Pharmaceutical University, Dalian University, Key Laboratory of Guangdong Province, Integrated Chinese Medicine (China) · ORCID：0000-0001-9434-9526

发表论文 6 篇 · 总被引 45 次 · h-index 3

代表论文

• Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA (2023 · Journal of Ethnopharmacology · 被引 22)
• Cepharanthine attenuates pulmonary fibrosis via modulating macrophage M2 polarization (2024 · BMC Pulmonary Medicine · 被引 11)
• The impact of YTHDF2-mediated NCOA4 methylation on myocardial ferroptosis (2025 · APOPTOSIS · 被引 9)
• Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte Pyroptosis (2022 · Evidence-based Complementary and Alternative Medicine · 被引 3)
• Stage-specific cadmium tolerance based on morphological and physiological characteristics in marine macroalgae Grateloupia turuturu and Pachymeniopsis lanceolata (2025 · Algal Research)
• Performance And Surge Capacity Evaluations of 1.2kv Sic Vdmosfets with Varied Jfet Width (2024 · SSRN Electronic Journal)